Hospira Healthcare Corporation v Kennedy Institute of Rheumatology
2015
A-303-15
Resolved (Interlocutory)
Patent Impeachment
Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Counsel to:
Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd. and Celltrion Inc.
The decision is reported
here.
Meet the team
Warren Sprigings
Partner
Mary McMillan
Counsel